Patent details

Basic Information

Publication number:

EP1658846

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP050272400

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol for treating hepatitis virus infections

French Title of Invention:

N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol pour traiter les infections par le virus de l'hépatite

German Title of Invention:

N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen

SPC Number:

Dates

Filing date:

14/02/2000

Grant date:

30/07/2008

EP Publication Date:

30/07/2008

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/05/2006

EP B1 Publication Date:

30/07/2008

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/02/2009

Expiration date:

14/02/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/02/2000

 

 

Name:

United Therapeutics Corporation

Address:

1735 Connecticut Avenue, N.W. Third Floor, Washington, DC 20009, United States (US)

Inventor

1

Name:

Mueller Richard, A.

Address:

United States (US)

2

Name:

Bryant Martin, L.

Address:

United States (US)

3

Name:

Partis Richard, A.

Address:

United States (US)

Priority

1

Priority Number:

119722 P

Priority Date:

12/02/1999

Priority Country:

United States (US)

2

Priority Number:

119856 P

Priority Date:

25/02/2015

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/445;

Filing date	Document type	Number of pages